Simplex Trading
TCON

Simplex Trading’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Simplex Trading’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45
Closed -$1K – 10420
2022
Q4 		$1K Hold
45
– – ﹤0.01% 8990
2022
Q3 		$1K Buy
45
+20
+80% +$764 ﹤0.01% 9711
2022
Q2 		$1K Sell
25
-5
-17% -$194 ﹤0.01% 9734
2022
Q1 		$1K Buy
30
+5
+20% +$251 ﹤0.01% 10187
2021
Q4 		$1K Buy
25
+5
+25% +$319 ﹤0.01% 10285
2021
Q3 		$2K Hold
20
– – ﹤0.01% 9584
2021
Q2 		$2K Buy
+20
New +$2.77K ﹤0.01% 9758
2021
Q1 		– Hold
0
– – – 8172
2020
Q4 		– Hold
0
– – – 7745

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's TCON Position: Q2 2023 in Review

Simplex Trading sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2023, closing a stake of 22 shares — an estimated $402 sold.

Simplex Trading first reported a position in TCON in Q4 2020 and held it in 5 quarters. The position peaked at $28K in Q1 2022. 27 funds tracked by Wall St. Rank hold TCON as of Q2 2023.

  • Simplex Trading reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 22 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $402.
  • Simplex Trading first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Simplex Trading's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $28K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.